Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients
NCT04922944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 167
Last updated 2024-09-19
Summary
This research study is studying how healthcare worker recipients react after receiving vaccinations for COVID-19. The objective of the study is to evaluate the immune response to COVID-19 vaccination. The immunity will be evaluated over time by measuring serum semi-quantitative SARS-Co-V2 IgG from blood specimens and analyzing vaccine reaction data. SARS-CoV-2 is the name for the virus responsible for COVID-19 infections. IgG, immunoglobulin G, is an antibody found in the blood that protects against bacterial and viral infections. Study subjects will also be asked to report physical reactions they may have experienced related to vaccinations.
Conditions
- Covid19
- Vaccine Reaction
Interventions
- DRUG
-
Two-dose COVID-19 vaccine
Sponsors & Collaborators
-
Huntington Memorial Hospital
lead OTHER
Principal Investigators
-
Kimberly Shriner, MD · Huntington Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-08
- Primary Completion
- 2022-03-01
- Completion
- 2022-03-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
COVID-19 Vaccine Induced Adaptive Immune Responses
NCT04729374 ·Status: UNKNOWN
-
Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations
NCT04944095 ·Status: UNKNOWN
-
A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans
NCT04852289 ·Status: ACTIVE_NOT_RECRUITING
-
Understanding Immunity to the COVID-19 Vaccines
NCT04664309 ·Status: COMPLETED
-
A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind
NCT05367908 ·Status: COMPLETED
-
Profiling Spike Protein Antibody Response Post COVID-19 Booster
NCT05476822 ·Status: WITHDRAWN
-
Study of Immune Response in Subjects Vaccinated Against SARS-CoV-2 Infection
NCT07049497 ·Status: COMPLETED
-
Adaptive Immune Response to COVID-19 Vaccination
NCT04826770 ·Status: ACTIVE_NOT_RECRUITING
-
COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells
NCT04402892 ·Status: UNKNOWN ·Phase: NA
-
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19
NCT04412538 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay
NCT04452318 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Immune Responses to the Virus That Causes COVID-19
NCT04431414 ·Status: COMPLETED
-
A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051
NCT03301090 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients
NCT04838821 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Methylation Effects of COV-19 Infection and Vaccinations
NCT04939155 ·Status: UNKNOWN
-
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
NCT04610502 ·Status: COMPLETED ·Phase: PHASE2
-
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2
NCT05329220 ·Status: COMPLETED ·Phase: PHASE3
-
Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines
NCT04889209 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease
NCT05043246 ·Status: UNKNOWN
-
A Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants
NCT05505448 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of an Acellular DPT Vaccine During Pregnancy
NCT01445743 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults
NCT05960097 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Associated Lymphopenia Pathogenesis Study in Blood
NCT04401436 ·Status: COMPLETED
-
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults
NCT00322946 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity of COVID-19 Vaccine on Heterologous Schedule
NCT05054621 ·Status: COMPLETED ·Phase: PHASE2